Biotek-snakken — December 2020
-
lanhn1- enig, der var et par SDs der sagtens kunne udvikle sig til PRs, samt nogle PRs der kunne blive til CRs
-
Gode nyheder fra Enlivex Covid-19 trial https://www.enlivex.com/investor-relations/#
-
STRA - data og link til webinar om lidt
- https://finance.yahoo.com/news/sutro-biopharma-announces-encouraging-interim-213000411.html -
Det begynder bestemt at ligne noget - Mersanas mcap er 150% større end Sutros, måske vi snart skal derop af? Data er i hvert fald meget sammenligneligt med d
eres -
Alligator - FDA godkender IND på mitazalimab (CD40) - https://alligatorbioscience.se/en/approved-ind-for-alligator-biosciences-cd40-targeting-antibody-mitazalimab/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Den er stadigvæk mega undervalued.